Advisory Committee on Heritable Disorders and Genetic Diseases in Newborns and Children; Notice of Meeting, 55494 [06-8018]
Download as PDF
<![CDATA[
55494
Federal Register / Vol. 71, No. 184 / Friday, September 22, 2006 / Notices
Send comments to Susan G. Queen,
Ph.D., HRSA Reports Clearance Officer,
Room 10–33, Parklawn Building, 5600
Fishers Lane, Rockville, MD 20857.
Written comments should be received
within 60 days of this notice.
Dated: September 15, 2006.
Cheryl R. Dammons,
Director, Division of Policy Review and
Coordination.
[FR Doc. 06–8020 Filed 9–21–06; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Dated: September 15, 2006.
Cheryl R. Dammons,
Director, Division of Policy Review and
Coordination.
[FR Doc. 06–8018 Filed 9–21–06; 8:45 am]
Health Resources and Services
Administration
Advisory Committee on Heritable
Disorders and Genetic Diseases in
Newborns and Children; Notice of
Meeting
BILLING CODE 4165–15–P
sroberts on PROD1PC70 with NOTICES
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), notice is hereby given
of the following meeting:
Name: Advisory Committee on Heritable
Disorders and Genetic Diseases in Newborns
and Children (ACHDGDNC).
Dates and Times: November 2, 2006, 9 a.m.
to 5 p.m. November 3, 2006, 8:30 a.m. to 3
p.m.
Place: Hilton Washington Hotel,
Georgetown Room, 1919 Connecticut
Avenue, NW., Washington, DC 20009.
Status: The meeting will be open to the
public with attendance limited to space
availability.
Purpose: The Committee was established
specifically to advise and guide the Secretary
regarding the most appropriate application of
universal newborn screening tests,
technologies, policies, guidelines and
programs for effectively reducing morbidity
and mortality in newborns and children
having or at risk for heritable disorders. The
Committee also provides advice and
recommendations concerning the grants and
projects authorized under the Heritable
Disorders Program and technical information
to develop policies and priorities for this
program. The Heritable Disorders Program
was established to enhance the ability of
State and local health agencies to provide for
newborn and child screening, counseling and
health care services for newborns and
children having or at risk for heritable
disorders.
Agenda: The meeting will include a report
on the nomination process for newborn
screening candidate conditions, as well as
the continued work and reports by the
Committee’s subcommittees on laboratory
standards and procedures, follow-up and
treatment, and education and training.
Proposed agenda items are subject to
change.
Time will be provided each day for public
comment. Individuals who wish to provide
public comment or who plan to attend the
VerDate Aug<31>2005
20:37 Sep 21, 2006
Jkt 208001
meeting and need special assistance, such as
sign language interpretation or other
reasonable accommodations, should notify
the ACHDGDNC Executive Secretary,
Michele A. Lloyd-Puryear, M.D., Ph.D.
(contact information provided below).
For Further Information Contact: Anyone
interested in obtaining a roster of members or
other relevant information should write or
contact Michele A. Lloyd-Puryear, M.D.,
Ph.D., Maternal and Child Health Bureau,
Health Resources and Services
Administration, Room 18A–19, Parklawn
Building, 5600 Fishers Lane, Rockville,
Maryland 20857, Telephone (301) 443–1080.
Information on the Advisory Committee is
available at https://mchb.hrsa.gov/programs/
genetics/committee.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
Notice of Meeting of the Advisory
Committee on Organ Transplantation
Health Resources and Services
Administration, HHS.
SUMMARY: Pursuant to Public Law 92–
463, the Federal Advisory Committee
Act, as amended (5 U.S.C. Appendix 2),
notice is hereby given of the eleventh
meeting of the Advisory Committee on
Organ Transplantation (ACOT),
Department of Health and Human
Services (HHS). The meeting will be
held from approximately 9 a.m. to 5:30
p.m. on November 2, 2006, and from 9
a.m. to 3 p.m. on November 3, 2006, at
the Bethesda DoubleTree Hotel, 8120
Wisconsin Avenue, Bethesda, MD
20814. The meeting will be open to the
public; however, seating is limited and
pre-registration is encouraged (see
below).
SUPPLEMENTARY INFORMATION: Under the
authority of 42 U.S.C. 217a, section 222
of the Public Health Service Act, as
amended, and 42 CFR 121.12 (2000),
ACOT was established to assist the
Secretary in enhancing organ donation,
ensuring that the system of organ
transplantation is grounded in the best
available medical science, and assuring
the public that the system is as effective
and equitable as possible, and, thereby,
increasing public confidence in the
integrity and effectiveness of the
transplantation system. ACOT is
composed of up to 25 members,
including the Chair. Members are
AGENCY:
PO 00000
Frm 00079
Fmt 4703
Sfmt 4703
serving as Special Government
Employees and have diverse
backgrounds in fields such as organ
donation, health care public policy,
transplantation medicine and surgery,
critical care medicine and other medical
specialties involved in the identification
and referral of donors, non-physician
transplant professions, nursing,
epidemiology, immunology, law and
bioethics, behavioral sciences,
economics and statistics, as well as
representatives of transplant candidates,
transplant recipients, organ donors, and
family members.
ACOT will hear presentations on the
revised Uniform Anatomical Gift Act;
the United Network for Organ Sharing
Department of Evaluation and Quality;
the Hollywood Health and Society
Project; new developments in
immunosuppression; and payment for
organs.
The draft meeting agenda will be
available on October 16 on the
Department’s donation Web site at
https://www.organdonor.gov/acot.html.
A registration form will be available
on October 2 on the Department’s
donation Web site at https://
www.organdonor.gov/acot.html. The
completed registration form should be
submitted by facsimile to Professional
and Scientific Associates (PSA), the
logistical support contractor for the
meeting, at fax number (703) 234–1701.
Individuals without access to the
Internet who wish to register may call
Sowjanya Kotakonda with PSA at (703)
234–1737. Registration can also be
completed electronically at https://
www.psava.com/dot/acot2006/.
Individuals who plan to attend the
meeting and need special assistance,
such as sign language interpretation or
other reasonable accommodations,
should notify the ACOT Executive
Secretary, Remy Aronoff, in advance of
the meeting. Mr. Aronoff may be
reached by telephone at 301–443–3264,
e-mail: Remy.Aronoff@hrsa.hhs.gov or
in writing at the address provided
below. Management and support
services for ACOT functions are
provided by the Division of
Transplantation, Healthcare Systems
Bureau, Health Resources and Services
Administration, 5600 Fishers Lane,
Parklawn Building, Room 12C–06,
Rockville, Maryland 20857; telephone
number 301–443–7577.
After the presentations and ACOT
discussions, members of the public will
have an opportunity to provide
comments. Because of the Committee’s
full agenda and the timeframe in which
to cover the agenda topics, public
comment will be limited. All public
E:\FR\FM\22SEN1.SGM
22SEN1
]]>Agencies
[Federal Register Volume 71, Number 184 (Friday, September 22, 2006)]
[Notices]
[Page 55494]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 06-8018]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Health Resources and Services Administration
Advisory Committee on Heritable Disorders and Genetic Diseases in
Newborns and Children; Notice of Meeting
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), notice is hereby given of the following
meeting:
Name: Advisory Committee on Heritable Disorders and Genetic
Diseases in Newborns and Children (ACHDGDNC).
Dates and Times: November 2, 2006, 9 a.m. to 5 p.m.November 3,
2006, 8:30 a.m. to 3 p.m.
Place: Hilton Washington Hotel, Georgetown Room, 1919
Connecticut Avenue, NW., Washington, DC 20009.
Status: The meeting will be open to the public with attendance
limited to space availability.
Purpose: The Committee was established specifically to advise
and guide the Secretary regarding the most appropriate application
of universal newborn screening tests, technologies, policies,
guidelines and programs for effectively reducing morbidity and
mortality in newborns and children having or at risk for heritable
disorders. The Committee also provides advice and recommendations
concerning the grants and projects authorized under the Heritable
Disorders Program and technical information to develop policies and
priorities for this program. The Heritable Disorders Program was
established to enhance the ability of State and local health
agencies to provide for newborn and child screening, counseling and
health care services for newborns and children having or at risk for
heritable disorders.
Agenda: The meeting will include a report on the nomination
process for newborn screening candidate conditions, as well as the
continued work and reports by the Committee's subcommittees on
laboratory standards and procedures, follow-up and treatment, and
education and training.
Proposed agenda items are subject to change.
Time will be provided each day for public comment. Individuals
who wish to provide public comment or who plan to attend the meeting
and need special assistance, such as sign language interpretation or
other reasonable accommodations, should notify the ACHDGDNC
Executive Secretary, Michele A. Lloyd-Puryear, M.D., Ph.D. (contact
information provided below).
For Further Information Contact: Anyone interested in obtaining
a roster of members or other relevant information should write or
contact Michele A. Lloyd-Puryear, M.D., Ph.D., Maternal and Child
Health Bureau, Health Resources and Services Administration, Room
18A-19, Parklawn Building, 5600 Fishers Lane, Rockville, Maryland
20857, Telephone (301) 443-1080. Information on the Advisory
Committee is available at https://mchb.hrsa.gov/programs/genetics/
committee.
Dated: September 15, 2006.
Cheryl R. Dammons,
Director, Division of Policy Review and Coordination.
[FR Doc. 06-8018 Filed 9-21-06; 8:45 am]
BILLING CODE 4165-15-P
